About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, May 27th, 2015

The QualityStocks
Daily Stock List


Grandparents.com, Inc. (GPCM)

Today we are reporting on Grandparents.com, Inc. (GPCM), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Grandparents.com, Inc. owns and operates the Grandparents.com website. The OTCQB-listed Company primarily serves the approximately 70 million grandparents in the United States. However, its audience also includes "boomers" and seniors who are not grandparents. The Company’s website offers advice on health and wellbeing, relationships, and finances. Additionally, it offers advice on recipes, travel tips, and recommended activities for grandparents, boomers, and seniors. Grandparents.com is headquartered in New York, New York.

In addition, Grandparents.com has established the American Grandparents Association (AGA). This is a membership association. AGA works to unite grandparents, boomers, and seniors around the concept that the age 50-plus demographic faces issues that are unique to them. Members of the AGA enjoy specific benefits. These include access to Grand Deals and other products and services provided by third parties, which Grandparents.com endorses or recommends. There are greater than 2 million members in the AGA.  Grandparents.com is the #2 website in the age 50-plus segment of the population.

Grandparents.com, so far, has produced revenue mainly from advertising. The Company continues to focus on creating additional revenue streams from other sources. These include Grand Deals, endorsement opportunities, and the Grand Card. Grand Deals makes available to AGA members’ giveaways, discounts, as well as other benefits on an array of products and services provided by the Company’s marketing partners.

These relate to travel, entertainment, food and dining, wellness, and online shopping. Marketing partners are asked to provide deals on products or services that are better than they otherwise provide to non-AGA members. Grandparents.com also plans to offer a paid-membership tier of the AGA.

In December 2014, Grandparents.com and its membership organization, the American Grandparents Association (AGA), announced that they entered into a partnership with Mothers Against Drunk Driving® (MADD). MADD is the nation's largest non-profit organization working to protect and support families by preventing drunk driving and underage drinking. The American Grandparents Association will donate $5 of the $15 annual American Grandparents Association membership fee paid by new and renewing MADD donors and supporters who join to help MADD attain its lifesaving mission.

Grandparents.com, Inc. (GPCM), closed Wednesday's trading session at $0.191, down 23.60%, on 23,729 volume with 10 trades. The average volume for the last 60 days is 37,436 and the stock's 52-week low/high is $0.1001/$0.54.

GlyEco, Inc. (GLYE)

RedChip reported this month on GlyEco, Inc. (GLYE), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

GlyEco, Inc. is a sustainable glycol technologies leader with corporate headquarters in Phoenix, Arizona. The Company is a green chemistry business with a patent-pending technology for transforming hazardous waste into green products. The technology enables its clients to handle the removal of waste glycol in a responsible and environmentally safe manner. GlyEco lists on the OTC Markets’ OTCQB.

GlyEco Technology™ has the unique ability to clean the polluted glycols from all five waste-producing industries. These industries are HVAC (heating, ventilation, and air conditioning), Textiles, Automotive, Airline, and Medical. The technology recycles waste glycol to meet ASTM Type 1 specifications. This is the same level of purity expected of refinery-grade glycols.

Therefore, GlyEco’s clients can treat glycols as a more sustainable resource, recycling and re-using waste glycols continually. The GlyEco Technology™ solution gives the Company’s clients a method to reduce waste while caring for the environment, and while decreasing their costs. GlyEco’s technology removes pollutants such as organic acids, esters, and high dissolved solids.

GlyEco announced last year that it commenced its second phase of expansion at its New Jersey processing center. This is to meet growing customer demand for its refinery-grade recycled glycol. The upgrades further expand its waste glycol processing capacity and storage capabilities. GlyEco also has its upgraded Landover, Maryland processing center. GlyEco completed substantial storage capacity and throughput upgrades in 2014 to facilitate a growth program. The Maryland processing center is its second highest-volume facility.

GlyEco has completed the installation of a new proprietary distillation system at its South Carolina Processing Center. This increases capacity by 300 percent. The new technology installation at this processing center considerably improves throughput with minimal impact to production time and costs. In addition, GlyEco has completed the initial build-out of its testing laboratory at its New Jersey Processing Center. Its intention is to offer chemical testing services to external customers this year.

This month, GlyEco announced financial results for its fiscal quarter ended March 31, 2015. Revenue was $1.34 million for the quarter ended March 31, 2015 versus $1.65 million for same period last year. This represents a decrease of $310,590 or 18.8 percent. Operating loss for the quarter improved by $210,713 to negative $935,851. This represents an improvement of 18.4 percent versus the negative $1.15 million of operating loss for the same period the year prior.

Net loss available to common shareholders for the quarter improved by $2.46 million to negative $978,766. This represents an improvement of 71.5 percent versus the negative $3.44 million of net income available to common shareholders for the same period last year. Basic loss per share was $(0.02) versus basic loss per share of $(0.07) for the same period the year prior.

GlyEco, Inc. (GLYE), closed Wednesday's trading session at $0.20, even for the day, on 5,000 volume with 2 trades. The average volume for the last 60 days is 65,883 and the stock's 52-week low/high is $0.12/$0.81.

Premier Biomedical, Inc. (BIEI)

PennyStocks24, Information Solutions Group, and FeedBlitz reported previously on Premier Biomedical, Inc. (BIEI), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Premier Biomedical, Inc. is a research-based medical development company. Its objective is to discover and develop medical treatments, in collaboration with the University of Texas at El Paso and the US Department of Defense, specifically targeting the treatment of Alzheimer's Disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease), Blood Sepsis and Viremia, and Cancer. Premier Biomedical is initially targeting the treatment of Alzheimer's disease, Traumatic Brain Injury, and Cancer. The Company is based in El Paso, Texas and also has offices in Pennsylvania.

Premier Biomedical is a medical development company specializing in breakthroughs for serious illnesses. It has licensed the technology behind many provisional patents in the U.S. and a PCT Europe National Patent in the areas of Cancer, Sepsis, and Multiple Sclerosis. It has developed an aggressive timetable to further the development of these technologies via the laboratory, hospital, and clinical trials. It has started the development of potential patient trial application lists.

Premier Biomedical announced in June 2014 that the United States Patent Office approved a patent on the Company’s proprietary medication Feldetrex ™. The design of this medication is to relieve the symptoms of neuropathic pain and fibromyalgia.

Premier Biomedical has been evaluating strategies to take its own Anti-CTLA4 breast cancer treatment through the Food and Drug Administration (FDA) approval process. Its experimentation on the efficacy of its unique, patent-pending formulation of an anti-CTLA-4 breast cancer drug on mice was presented at the peer-reviewed April 5-9, 2014 American Association for Cancer Research Symposium in San Diego, California.

The Company has several other continuing projects, in addition to its Anti-CTLA-4-based breast cancer drug. In two upcoming clinical trials, its plan is to test its Feldetrex™ pain medication, followed by a separate clinical trial of its core technology designed to remove the pathophysiological basis of the disease.

This past February, Premier Biomedical announced that it developed and filed a Request for Designation of Duchenne Muscular Dystrophy as a rare disease, preparing the way for a formal "Humanitarian Use Device" (HUD) application for the Company’s treatment and potential cure for the disease. A United States Patent application for this treatment methodology was filed in Q3 2014.

Last month, Premier Biomedical announced that it signed a Patent License Agreement with the University of Texas El Paso (UTEP), covering the cancer treatment process called "CD152-LDMC" that the two entities have been developing in cooperation at the Border Biomedical Research Center, located in UTEP's $45-million Bioscience Research Building. The proprietary process strives to block a molecule called cytotoxic T-lymphocyte antigen or CTLA-4, through combining CTLA-4 blocking antibody CD152, along with Low Dose Metronomic Chemotherapy. Major progress has been made over the past year advancing the development of CD152-LDMC.

Premier Biomedical, Inc. (BIEI), closed Wednesday's trading session at $0.139, even for the day, on 7,750 volume with 3 trades. The average volume for the last 60 days is 6,188 and the stock's 52-week low/high is $0.0551/$0.54.

Yappn Corp. (YPPN)

SmallCapFinancialWire, PennyStocks24, Shiznit Stocks, MyBestStockAlerts, Fast Money Alerts, Penny Stock General, and Stock Shock and Awe reported on Yappn Corp. (YPPN), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Yappn Corp. is a real-time multilingual services company that amplifies brand messaging, helps conduct commerce, and provides customer support through globalizing these experiences with its proprietary approach to language. Yappn provides people and brands the power to be social, conduct commerce, and communicate freely without a language barrier.

Yappn is where people can meet, chat, engage, and consume content in 67 languages through the Company’s Real Time Multilingual Amplification platform. Yappn is free for users who want to participate on the Company’s general discussion board, unless otherwise noted.

A user’s language is detected by their browser setting automatically. At the very bottom of the page, a user will find a translator bar with the option to select many languages. A user chooses their language and all Yappn pages instantly translate. Yappn members can participate individually or in groups, regardless of the language they speak. Everything a person sees on Yappn is in their language, irrespective of the language in which it was initially posted.

Yappn rooms are places to discuss topics of interest to the Yappn community. Yappn rooms are user-generated. The online Yappn community can decide what ends up on the principal discussion page. All of a user’s live rooms can be customized to their preference. Users can link their Yappn profile to their Facebook, Twitter, LinkedIn, Windows Live, Foursquare, Github, and Google+ accounts.

Yappn is rolling out its global media and social sharing platform, FotoYapp, in major app stores for iPad ®, iPhones® and Android® devices. FotoYapp enables viewers and users around the world to share images, 18 second video and social comments in their native language, promoting Global Storytelling together with social networking sites in almost any language.

Yappn has launched, in combination with its multilingual content network program with Digital Widget Factory (DWF), Yadmark, Inc. and Yaffiliate Marketing Services, Inc. Yadmark will schedule and support DWF's revenue programs related to direct and network online advertising. Yaffiliate will schedule and support all DWF's affiliate and eCommerce partnerships.

Yappn has also launched the branding of its global Ecommerce technology and services platform Windrose Tech (www.windrosetech.com). Windrose Tech was established to provide a clear and distinct brand for Yappn's proprietary suite of multilingual Marketing (pre-sale), Store (catalog, shopping cart and checkout), and Customer Support (post-sale) offerings for small, medium and enterprise customers who want to sell their online goods and services effortlessly in their clients’ native languages. Furthermore, Yappn is developing, Wonring.com (www.wonring.com). This is a global platform, online, mobile and app, to connect major social networks together through a single interface, permitting commercial and personal instant text and voice messaging in up to 67 languages.

This week, Yappn announced that it signed a non-binding Letter of Intent (LOI) to acquire key assets of Ortsbo Inc., a division of Intertainment Media, Inc. (ITMTF). This includes US Patent No. 8,983,850 B2, proprietary language services technology assets, expertise related to Ecommerce and Customer Care and business contracts for a total purchase price of US $17 Million.

Yappn Corp. (YPPN), closed Wednesday's trading session at $0.051, even for the day, on 83,400 volume with 6 trades. The average volume for the last 60 days is 47,523 and the stock's 52-week low/high is $0.02/$0.20.

Stevia First Corp. (STVF)

Investors Alley, Wall Street Resources, TopStockAnalysts, and Investor Relations reported recently on Stevia First Corp. (STVF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Stevia First Corp. is an agricultural biotechnology company based in California's Central Valley growing region. The Company is concentrating on the industrial scale production of stevia. Stevia is an all-natural zero-calorie sweetener. Stevia First develops proprietary fermentation technologies for production of stevia, an alternative sweetener. The Company is based in Yuba City, California. Stevia First’s shares trade on the OTC Markets Group’s OTCQB.

Stevia is a plant from the sunflower family that is native to Paraguay.  The leaf of the stevia plant has 9 to 12 sweet-tasting compounds called steviol glycosides. This includes Stevioside (STV) and Rebaudioside A, the sweetest and best tasting of the compounds. Very high purity (95 percent or higher) extracted from the stevia leaf is known as Reb A. This is used in powder or liquid form to increase the intensity of sweeteners in a food, beverage, or tabletop sweetener and/or to improve taste.

Stevia First is working to establish a vertically-integrated enterprise in the United States that uses technological expertise in fermentation-based stevia production and improves upon traditional stevia farming and processing methods. It launched in 2011 with a purpose to provide a healthy mainstream solution for the twin diabetes and obesity epidemics.

This past March, Stevia First announced that it entered into a scientific collaboration with BioViva Sciences to advance genetic therapies for the alleviation of human diabetes and obesity. BioViva is developing novel gene therapy protocols where single-dose administrations can have lasting and potentially life-long benefits on human health. Stevia First’s geroprotector development program is focused towards identifying novel genes, drugs, and nutritional products that influence lifespan, and that could have a great effect on human metabolism.

This month, Stevia First announced that it has been granted membership into the United Nations Global Compact (UNGC). This is a strategic policy initiative for businesses that are dedicated to aligning their operations and strategies with ten universally accepted principals in the areas of human rights, labor, environment, and also anti-corruption.

Stevia First Corp. (STVF), closed Wednesday's trading session at $0.24, even for the day, on 134,153 volume with 51 trades. The average volume for the last 60 days is 202,461 and the stock's 52-week low/high is $0.14/$0.48.


The QualityStocks
Company Corner


View Systems, Inc. (VSYM)

The QualityStocks Daily Newsletter would like to spotlight View Systems, Inc. (VSYM). Today, View Systems, Inc. closed trading at $0.0059, up 18.00%, on 514,634 volume with 9 trades. The stock’s average daily volume over the past 60 days is 580,112, and its 52-week low/high is $0.005/$0.0325.

View Systems, Inc. announced that it has engaged the investor relations services of QualityStocks. Based in Scottsdale, Arizona, QualityStocks has assisted more than 300 public companies with their efforts to broaden influence, attract growth capital and improve shareholder value. QualityStocks will use its vast network of partners, daily and weekly newsletters, social media channels, blog and other outreach tools to enhance View Systems' visibility and market recognition while creating a new dimension of communication and transparency between the Company and the investment community.

View Systems, Inc. (VSYM) is a leading security technology products company with “state-of-the-art” technological solutions for modern security problems. Targeting the challenging business opportunities in the opening decades of the 21st century and beyond, View Systems has solutions for law enforcement facilities such as correctional institutions as well as other government agencies, schools, courthouses, event and sports venues, the military and commercial businesses.

The senior management team is comprised of successful businessmen with decades of business and professional experience in the security industry. The approach used by View Systems utilizes the expertise of this team to provide innovative solutions to security problems with reliable “cutting edge” products in conjunction with client-oriented security consulting services.

The company’s flagship product, ViewScan, is an advanced walk-through Concealed Weapons Detection System (CWD) that greatly simplifies the process of discriminating suspicious items from harmless ones. The highly sensitive, completely passive sensor technology powering the system accurately detects the location and number of threat objects such as knives, guns and razor blades while ignoring personal artifacts like coins, keys and belt buckles. A portable version of this system has only a fifteen minute setup time using only a screwdriver and it easily fits inside a golf size case.

Experts say the security industry has been the fastest-growing sector of the global economy during the past decade. Today, it is conservatively estimated to be a $100 billion-a-year industry and growing. As the business environment continues to get more complex, especially in foreign markets, View Systems is strategically positioned to capitalize on unsurpassed opportunity. Disclaimer

View Systems, Inc. Company Blog

View Systems, Inc. News:

View Systems, Inc. (VSYM) Announces Engagement of QualityStocks Investor Relations Services

View Partners With Maryland XSIG Minority Business Enterprise

View Files for Patent of a New Enhanced ViewScan

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.05, up 4.17%, on 237,025 volume with 22 trades. The stock’s average daily volume over the past 60 days is 868,149, and its 52-week low/high is $0.045/$0.1589.

International Stem Cell Corp. announced today that the company has been selected to give an oral presentation on its preclinical studies in Parkinson's at the 21st annual meeting of the International Society for Cellular Therapy in Las Vegas. ISCO's chief scientific officer, Ruslan Semechkin, Ph.D., will discuss the data at the "Regeneration and Nervous System Repair" session at 11:45 a.m. on May 30, 2015 in a presentation entitled "Human Parthenogenetic Derived Neural Stem Cells for the Treatment of Parkinson's Disease."

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation to Present at International Society for Cellular Therapy Annual Meeting

International Stem Cell Corporation Announces 2015 First Quarter Results

International Stem Cell Corporation Publishes Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation

Pure Hospitality Solutions, Inc. (PNOW)

The QualityStocks Daily Newsletter would like to spotlight Pure Hospitality Solutions, Inc. (PNOW). Today, Pure Hospitality Solutions, Inc. closed trading at $0.0019, up 5.56%, on 6,080,790 volume with 40 trades. The stock’s average daily volume over the past 60 days is 1,941,893, and its 52-week low/high is $0.0013/$0.5882.

Pure Hospitality Solutions, Inc. announced today, that Pure Hospitality Solutions teams up with Investors Hangout, to offer an additional investor information board to inform shareholders about the Company. Interested parties can visit the new Investor board and discuss Pure Hospitality solutions at http://investorshangout.com/Pure-Hospitality-Solutions-Inc-PNOW-65267/.

Pure Hospitality Solutions, Inc. (PNOW) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.

The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Pure continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.

Operating a successful bi-lateral business model, Pure has four objectives:

1.   To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;

2.   Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;

3.   Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,

4.   Expand the portfolio of Pure-owned boutique hotels operating under the Hotel PURE brand.

The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.

Ultimately, Pure intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer

Pure Hospitality Solutions, Inc. Company Blog

Pure Hospitality Solutions, Inc. News:

Pure Hospitality Solutions Teams up with Investors Hangout

Pure Hospitality Solutions Ramps Up Coding Integration

Pure Joins Sabre's $7 Billion Travel Network Family

Mobile Lads Corp. (MOBO)

The QualityStocks Daily Newsletter would like to spotlight Mobile Lads Corp. (MOBO). Today, Mobile Lads Corp. closed trading at $0.11, up 54.14%, on 21,140 volume with 2 trades. The stock’s average daily volume over the past 60 days is 31,113, and its 52-week low/high is $0.05/$0.42.

Mobile Lads Corp. (MOBO) designs and delivers secure, wide-area wireless transaction software solutions for the consumer finance, web and health payment processing sectors. The company’s solutions provide streamlined, continuous access to time-sensitive information and data on multiple network standards. Mobile Lads’ products and services, offered through its Xtreme Mobility division, centers on three core technologies that simplify and secure wireless communications: xmVerify, xmBilling, and xmOne.

xmVerify is a real-time mobile transaction security service that prevents credit card fraud by giving users control over the authorization process when making purchases. Using one of the best cryptographic services, and in compliance with most all available platforms, xmVerify sends a transaction authorization request directly to the user’s mobile phone to ensure authenticity.

xmBilling is a mobile platform that provides customers with a convenient and secure way to review and authorize automatic billing transactions, easing the challenges of automated and volume-based billing. The system sends the user a text message with a URL leading to an online e-bill where they can review details of the bill and authorize the payment via credit card with the use of their PIN number.

The xmOne mobile platform provides an array of encrypted mobile services, including top-up, payment processing, emergency notification and marketing, ideal for students and higher education facilities. xmOne interfaces with a school’s existing campus card account system to enable students to perform a variety of banking transactions from their cell phones. The university or college benefits from increased usage of the flex-dollar ecosystem, reduces overhead from ADMs, and can be customized to each school’s individual brand.

Mobile Lads is guided by a management team with a unique blend of in-depth technical expertise in wireless channel communications and a solid background in business strategy and consumer analysis. The company’s vision is to grow as a leading-edge wireless solution provider by enabling innovative, wide-area communication solutions on a global scale. Disclaimer

Mobile Lads Corp. Company Blog

Mobile Lads Corp. News:

Mobile Lads Begins Operating And Buys Control Of North American Shopping Network Simbadeals.com From DoMark International

Mobile Lads Begins Operating North American Shopping Network Simbadeals.com

Mobile Lads Purchases Majority of North American Shopping Network From Domark International

Growblox Sciences, Inc. (GBLX)

The QualityStocks Daily Newsletter would like to spotlight Growblox Sciences, Inc. (GBLX). Today, Growblox Sciences, Inc. closed trading at $0.37, up 16.44%, on 52,319 volume with 36 trades. The stock’s average daily volume over the past 60 days is 64,469, and its 52-week low/high is $0.151/$3.49.

Growblox Sciences, Inc. (GBLX), a biopharmaceutical research and development company, is focused on creating safe, standardized pharmaceutical-grade cannabis-based therapies for various medical conditions. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country.

The company’s GrowBLOX technology suite includes the TissueBLOX, GrowBLOX, and CureBLOX equipment. Together, these components provide unparalleled control and monitoring of cannabis cultivation throughout the plant's life-cycle. These patent pending processes were designed to produce a safe and consistent cannabis product under cGMP guidelines. Utilizing a computer-regulated system that optimizes the nutrients, water, temperature, and gas levels, the GrowBLOX suite produces cannabis with more active ingredients per pound than traditional cultivation methods.

Also, based on an analysis of preclinical and clinical data from thousands of peer-reviewed studies, Growblox Sciences has identified the most effective profiles of cannabinoids and terpenes for the treatment of conditions within seven therapeutic categories. As a result of this extensive research and the analysis of the active ingredient profiles of 30,000 Cannabis strains in conjunction with a major testing lab, the company will be able to provide patients with natural cannabis strains containing the ideal ratios for treating specific diseases or symptoms.

Another significant advantage held by the company stems from an accelerated drug development program to finish in 3-5 years instead of the 15-20 years typically seen in traditional pharmaceutical development programs. Armed with an intellectual property strategy that takes full advantage of the design of the GrowBLOX technology suite and protects the valuable foundation laid, Growblox Sciences has positioned itself well for long-term success in the burgeoning cannabis space. Disclaimer

Growblox Sciences, Inc. Company Blog

Growblox Sciences, Inc. News:

GrowBLOX Announces Deployment of Commercial Units

Growblox Sciences, Inc. (GBLX) is “One to Watch”

Growblox Announces Commercialization Initiative and Financing


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



INO.com Market Report





By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251